You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Longitudinal sequencing from individuals with prolonged SARS-CoV-2 has some different attributes than spot sequencing of individual cases. Can the metadata standards be updated to handle longitudinal sampling?
Some considerations:
How should prolonged infections be differentiated from reinfections?
For prolonged infections, could symptom_onset_date be elevated to required when a prolonged infection is suspected, so that sample timing relative to initial symptom onset can be computed?
Can this information be mapped to Biosample submissions so that NCBI datasets from known prolonged infections can be readily identified?
Thanks!
dave
The text was updated successfully, but these errors were encountered:
Longitudinal sequencing from individuals with prolonged SARS-CoV-2 has some different attributes than spot sequencing of individual cases. Can the metadata standards be updated to handle longitudinal sampling?
Some considerations:
symptom_onset_date
be elevated to required when a prolonged infection is suspected, so that sample timing relative to initial symptom onset can be computed?Thanks!
dave
The text was updated successfully, but these errors were encountered: